½ÃÀ庸°í¼­
»óǰÄÚµå
1460121

´ëÀå ³»½Ã°æ ±â±â ½ÃÀå - Á¦Ç° À¯Çü, ¿ëµµ ¹× ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2024-2032³â)

Colonoscopy Devices Market - By Product Type (Colonoscope, Visualization Systems), Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohns Disease), End-use (Hospitals, Ambulatory Surgical Centers) - Global Forecast, 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ´ëÀå¾Ï ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ´ëÀå ³»½Ã°æ ±â±â ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 5%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, ´ëÀå¾ÏÀº Àü ¼¼°è¿¡¼­ ¼¼ ¹øÂ°·Î ¹ßº´ ºóµµ°¡ ³ôÀº Áúº´À¸·Î Àüü ¾Ï Áø´ÜÀÇ ¾à 10%¸¦ Â÷ÁöÇÏ¸ç ¾Ï °ü·Ã »ç¸Á ¿øÀÎ Áß µÎ ¹øÂ°·Î ³ôÀº ºñÁßÀ» Â÷ÁöÇÕ´Ï´Ù. ¼¼°è Àα¸ÀÇ ±Þ¼ÓÇÑ °í·ÉÈ­¿Í ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­·Î ´ëÀå¾ÏÀÇ À¯º´·üÀº °è¼Ó Áõ°¡Çϰí ÀÖÀ¸¸ç, ´ëÀå³»½Ã°æ °Ë»ç¹ý°ú Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³¼±µÈ ¿µ»ó ¹× ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ µî ´ëÀå³»½Ã°æ ÀåÄ¡ÀÇ Ã·´Ü ±â¼úÀº Áø´Ü Á¤È®µµ¸¦ Çâ»ó½ÃÄÑ ¾÷°è ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù Magentiq´Â AI Áö¿ø ´ëÀå³»½Ã°æ °Ë»ç µµ±¸¸¦ Ãâ½ÃÇÏ¿© ¼±Á¾ ½Äº° ¹× Á¦°ÅÀ²À» 7% Çâ»ó½ÃŰ°í ´ëÀå¾Ï ¹ß»ý °¡´É¼ºÀ» ³·Ãß¾ú½À´Ï´Ù.

´ëÀå ³»½Ã°æ °Ë»ç ÀåÄ¡ »ê¾÷Àº Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªÀ¸·Î ±¸ºÐµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ½Ã°¢È­ ½Ã½ºÅÛ ºÎ¹® ½ÃÀå °¡Ä¡´Â 2024-2032³â ¿¬Æò±Õ 4.9%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. °íÈ­Áú(HD) ¹× ÃʰíÈ­Áú(UHD) Ä«¸Þ¶ó, Çù´ë¿ª À̹Ì¡(NBI) ±â¼ú ¹× °¡»ó Ä÷¯ ³»½Ã°æ ±â¼ú°ú °°Àº Çõ½ÅÀº ´ëÀå ÁúȯÀÇ Å½Áö ¹× Áø´ÜÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ½Ã°¢È­ ½Ã½ºÅÛÀº ´ëÀåÀÇ ¼±¸íÇÏ°í »ó¼¼ÇÑ À̹ÌÁö¸¦ Á¦°øÇÏ¿© º´º¯ ½Äº° Á¤È®µµ¸¦ ³ôÀÌ°í ´©¶ô·üÀ» ³·Ãä´Ï´Ù. ¶ÇÇÑ, AI Áö¿ø À̹ÌÁö ºÐ¼®ÀÇ ÅëÇÕÀº Áø´Ü ´É·ÂÀ» ´õ¿í Çâ»ó½ÃÄÑ Á¦Ç° ¼ö¿ëÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¿ëµµº°·Î´Â ¸°Ä¡ ÁõÈıº ºÎ¹® ´ëÀå ³»½Ã°æ ±â±â ½ÃÀåÀº 2032³â±îÁö 4.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸°Ä¡ ÁõÈıº(LS)Àº À¯Àü¼º ´ëÀå¾Ï(CRC) Áß °¡Àå ³Î¸® ÆÛÁ® ÀÖ´Â ÁúȯÀ¸·Î, Àα¸ÀÇ 2%-3%ÀÇ ºóµµ·Î ¹ß»ýÇÕ´Ï´Ù. ÀÌ ÁúȯÀÇ È®»êÀ¸·Î Á¶±â ¹ß°ß°ú °¨½Ã¸¦ À§ÇÑ Á¤±âÀûÀÎ ´ëÀå³»½Ã°æ °Ë»çÀÇ Çʿ伺ÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¸°Ä¡ ÁõÈıºÀÇ À¯º´·ü Áõ°¡¿Í ÀÎ½Ä Áõ°¡, À¯ÀüÀÚ °Ë»ç·Î ÀÎÇØ È¿°úÀûÀÎ ½ºÅ©¸®´× ¹× ¸ð´ÏÅ͸µÀ» À§ÇØ Á¶Á¤µÈ ´ëÀå ³»½Ã°æ °Ë»ç Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ä÷¯ ³»½Ã°æ ¹× °íÈ­Áú ¿µ»ó°ú °°Àº ÷´Ü ±â¼úÀº ¸°Ä¡ ÁõÈıº ȯÀÚ¿¡°Ô Áß¿äÇÑ º´º¯ ¹ß°ß·üÀ» ³ô¿© ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î º¸¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´ëÀå ³»½Ã°æ ±â±â »ê¾÷Àº 2024³âºÎÅÍ 2032³â±îÁö 6.2%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ëÀå¾Ï¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϸ鼭 ´ëÀå³»½Ã°æ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±Çϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêÀÌ °­È­µÇ¸é¼­ ¿¹¹æÀû °Ç°­°ü¸®°¡ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ Àα¸ °í·ÉÈ­¿Í ½Ä½À°ü º¯È­·Î ÀÎÇØ ´ëÀå ÁúȯÀÌ Áõ°¡Çϰí ÀÖ¾î ´õ ¸¹Àº °ËÁø °Ë»ç°¡ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ±â¼úÀÇ ¹ßÀü°ú ÃÖ¼Ò Ä§½ÀÀû ½Ã¼úÀÇ Ã¤Åà Áõ°¡µµ ÀÌ Áö¿ª ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©£¦°úÁ¦
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • »óȯ ½Ã³ª¸®¿À
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • °¸ ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç° À¯Çüº°, 2018³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ´ëÀå ³»½Ã°æ
  • ½Ã°¢È­ ½Ã½ºÅÛ
  • ±âŸ Á¦Ç° À¯Çü

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2018³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ´ëÀå¾Ï
  • ¸°Ä¡ ÁõÈıº
  • ±Ë¾ç¼º ´ëÀå¿°
  • Å©·Ðº´
  • ±âŸ ¿ëµµ

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2018³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2018³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • Endomed Systems
  • Fujifilm Holdings Corporation
  • GI-View
  • Medtronic plc
  • Olympus Corporation
  • Ottomed Endoscopy
  • PENTAX Medical
  • Smart Medical Systems Ltd.
  • Steris PLC
  • Stryker Corporation
LSH 24.04.30

Colonoscopy Devices Market size is poised to expand at 5% CAGR from 2024 to 2032 driven by the increasing incidence of colorectal cancer worldwide.

As per WHO, colorectal cancer is the third most frequent disease in the world, accounting for around 10% of all cancer diagnoses, and the second biggest cause of cancer-related fatalities. With the rapidly aging global population and lifestyle changes, the prevalence of colorectal cancer will continue to rise, fueling the demand for colonoscopy procedures and devices. Additionally, advanced technologies in colonoscopy devices, such as improved imaging and navigation systems are enhancing diagnostic accuracy, further accelerating the industry growth. For instance, in February 2024, Magentiq launched its AI-aided colonoscopy tool to improve the identification and removal of adenomas by 7%, lowering the chance of getting colorectal cancer.

The colonoscopy devices industry is segmented in product type, application, end-use, and region.

In terms of product type, the market value from the visualization systems segment is anticipated to witness 4.9% CAGR from 2024-2032. Innovations, such as high-definition (HD) and ultra-high-definition (UHD) cameras, along with narrow-band imaging (NBI) and virtual chromoendoscopy technologies are enhancing the detection and diagnosis of colorectal diseases. These advanced visualization systems offer clearer, detailed images of the colon for improving accuracy in lesion identification and reducing miss rates. Additionally, the integration of AI-assisted image analysis is further augmenting the diagnostic capabilities, fueling the product acceptance significantly.

Based on application, the colonoscopy devices market from the Lynch syndrome segment is projected to record 4.6% CAGR through 2032. Lynch syndrome (LS) is the most prevalent hereditary colorectal cancer (CRC) condition, with a population frequency ranging from 2% to 3%. This disease penetration is surging the need for regular colonoscopies for early detection and surveillance. The rising prevalence of Lynch Syndrome, coupled with increasing awareness and genetic testing is driving the demand for colonoscopy devices tailored for effective screening and monitoring. Advanced technologies, such as chromoendoscopy and high-definition imaging are also enhancing the rate of lesion detection crucial for Lynch Syndrome patients, boosting the segment growth.

Regionally, the Asia Pacific colonoscopy devices industry is projected to exhibit 6.2% growth rate from 2024-2032. The increasing awareness about colorectal cancer coupled with rising healthcare expenditures are fueling the demand for colonoscopy procedures. The growing government efforts to improve healthcare infrastructure is promoting preventive healthcare. Additionally, the aging population and changing dietary habits in the region are contributing to the rise in colorectal diseases, necessitating more screening procedures. Moreover, advancements in medical technologies and the higher adoption of minimally invasive procedures are also driving the regional market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising demand for minimally invasive procedures
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Increasing incidence and prevalence of colorectal cancer
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risk associated with colonoscopy procedures
  • 3.3 Growth potential analysis
  • 3.4 Porter's analysis
    • 3.4.1 Supplier power
    • 3.4.2 Buyer power
    • 3.4.3 Threat of new entrants
    • 3.4.4 Threat of substitutes
    • 3.4.5 Industry rivalry
  • 3.5 PESTEL analysis
  • 3.6 Reimbursement scenario
  • 3.7 Regulatory landscape
  • 3.8 Technological landscape
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Colonoscope
  • 5.3 Visualization systems
  • 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Colorectal cancer
  • 6.3 Lynch syndrome
  • 6.4 Ulcerative colitis
  • 6.5 Crohn's disease
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Endomed Systems
  • 9.2 Fujifilm Holdings Corporation
  • 9.3 GI-View
  • 9.4 Medtronic plc
  • 9.5 Olympus Corporation
  • 9.6 Ottomed Endoscopy
  • 9.7 PENTAX Medical
  • 9.8 Smart Medical Systems Ltd.
  • 9.9 Steris PLC
  • 9.10 Stryker Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦